-
Marketwire - Thu Dec 10, 9:12 am ET
LONDON, ONTARIO--(Marketwire - Dec. 10, 2009) - Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced fiscal 2010 second quarter financial results today for the three and six month periods ended October 31, 2009. "We have achieved strong scientific results from our research and development programs during the quarter, and have worked hard to raise awareness of our technology and ...
-
Bloomberg - Thu Dec 10, 9:11 am ET
Dec. 10 (Bloomberg) -- Eli Lilly & Co., facing generic competition to its top-selling drug in 2011, plans to introduce two new medicines a year starting in 2013 and focus on treatments for Alzheimer’s disease, diabetes and cancer.
-
Business Wire via Yahoo! Finance - Thu Dec 10, 8:55 am ET
WINSTON-SALEM, N.C.----Targacept, Inc. , a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
-
Marketwire - Thu Dec 10, 8:42 am ET
CALGARY, ALBERTA--(Marketwire - Dec. 10, 2009) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) announced today that it has been granted U.S. Patent No. 7,604,993 entitled "Combined Regulation of Neural Cell Production". The claims cover the use of prolactin in combination with a variety of other biological agents for producing neuronal or glial precursor cells in vivo or in vitro. Dr ...
-
Reuters via Yahoo! News - Thu Dec 10, 8:29 am ET
Eli Lilly and Co forecast 2010 earnings in line with Wall Street expectations but gave no hint of how profit might pan out after its biggest drugs lose patent protection between 2011 and 2014.
-
Marketwire - Thu Dec 10, 8:14 am ET
NEW YORK, NY--(Marketwire - December 10, 2009) - GP Publishing has just released "The Miracle of ViaViente," authored by world renowned medical journalist Dr. Morton Walker. Dr. Walker has devoted his career to researching and writing about nutrition and human health and is the author of more than 100 books and 5400 articles. He states, "Until coming across ViaViente, I have never seen a more ...
-
San Francisco Chronicle - Thu Dec 10, 7:40 am ET
Eli Lilly & Co. said Thursday earnings per share could grow more than 10 percent next year, but the drugmaker's stock dropped as its 2009 forecast fell short of Wall Street expectations. Indianapolis-based Lilly also touted its pipeline of drugs under... Eli Lilly - Earnings per share - Business - Business and Economy - Health
-
The Auburn Citizen - Fri Dec 11, 10:01 pm ET
A Fulton man charged with driving while intoxicated and murder for allegedly ramming another man's truck into oncoming traffic in the town of Cato has been deemed mentally competent, officials said Friday.
-
The Arizona Republic - Fri Dec 11, 6:23 pm ET
Kenneth McKee, an 84-year-old with Alzheimer's, was last seen about 2 p.m. Thursday.
-
Nutraingredients.com - Fri Dec 11, 11:43 am ET
Bob Capelli, the company’s vice president sales and marketing told NutraIngredientsUSA.com: “This discovery is particularly interesting because it shows that we still have more to learn about Spirulina’s value to human health—after 30 years of commercialization, we are still discovering new nutrients in Spirulina and additional benefits that can be derived through its use.”
-
The Palladium-Times - Fri Dec 11, 11:16 am ET
awithers@palltimes.com
-
Marketwire via Yahoo! Finance - Fri Dec 11, 8:30 am ET
CALGARY, ALBERTA--(Marketwire - 12/11/09) - Stem Cell Therapeutics Corp. ("SCT") (TSX-V: SSS - News ) announced today that it has been granted U.S. Patent No. 7,629,169 entitled "Methods for the Production of Platelet-Derived Growth Factor-Responsive Neural Precursor Cells". The claims cover methods of producing and self-renewing PDGF-responsive precursor ("PRP") cells in culture using PDGF and ...
-
North Platte Telegraph - Fri Dec 11, 5:49 am ET
The North Platte Telegraph Just about anyone in the North Platte area who has had a loved one with Alzheimer's knows Helen Bell. In addition to facilitating two support groups for families of Alzheimer's patients, Bell has helped organize the annual North Platte Memory Walk as a fundraiser for the Alzheimer's Association.
-
Spring-Ford Reporter & Valley Item - Fri Dec 11, 5:35 am ET
DateBook Notes
-
OfficialWire - Fri Dec 11, 4:56 am ET
The "Medivation, Inc. - Financial and Strategic Analysis Review" is an in-depth business, strategic and financial analysis of Medivation, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors.